Merck KGaA (MKGAF)
OTCMKTS · Delayed Price · Currency is USD
127.40
+4.01 (3.25%)
Sep 15, 2025, 3:56 PM EDT
Merck KGaA Market Cap
Merck KGaA has a market cap or net worth of $54.56 billion as of September 15, 2025. Its market cap has decreased by -34.65% in one year.
Market Cap
54.56B
Enterprise Value
63.86B
Revenue
24.92B
Ranking
n/a
PE Ratio
16.23
Stock Price
$127.40
Market Cap Chart
Since April 7, 1997, Merck KGaA's market cap has increased from 6.76B to 54.56B, an increase of 706.88%. That is a compound annual growth rate of 7.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 54.56B | -13.54% |
| Dec 30, 2024 | 63.11B | -8.87% |
| Dec 29, 2023 | 69.25B | -17.61% |
| Dec 30, 2022 | 84.06B | -24.78% |
| Dec 30, 2021 | 111.75B | 49.03% |
| Dec 30, 2020 | 74.98B | 45.94% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |